NCT00660374View on ClinicalTrials.gov

Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL

Enrollment

402

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin NPH

"Soft-treat-to-target dose titration scheme, injection s.c."

DRUG

EX1000

"Soft-treat-to-target dose titration scheme, injection s.c."

Trial Locations (1)

40420-000

Salvador

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY